3.8624
Schlusskurs vom Vortag:
$3.87
Offen:
$3.85
24-Stunden-Volumen:
387.24K
Relative Volume:
0.28
Marktkapitalisierung:
$244.06M
Einnahmen:
$267.06M
Nettoeinkommen (Verlust:
$-69.17M
KGV:
-3.4162
EPS:
-1.1306
Netto-Cashflow:
$-22.38M
1W Leistung:
-4.22%
1M Leistung:
+29.10%
6M Leistung:
+10.29%
1J Leistung:
-23.56%
Aurora Cannabis Inc. Stock (ACB) Company Profile
Firmenname
Aurora Cannabis Inc.
Sektor
Telefon
-
Adresse
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ACB
Aurora Cannabis Inc.
|
3.855 | 245.01M | 267.06M | -69.17M | -22.38M | -1.1306 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.25 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
73.58 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
503.10 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-11 | Eingeleitet | TD Cowen | Buy |
| 2024-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-09-21 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-24 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-06-06 | Hochstufung | Stifel | Sell → Hold |
| 2021-09-28 | Hochstufung | MKM Partners | Sell → Neutral |
| 2021-09-03 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-05-14 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-05-14 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-05-11 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-04-28 | Fortgesetzt | BofA Securities | Neutral |
| 2021-02-12 | Herabstufung | Desjardins | Hold → Sell |
| 2021-02-12 | Herabstufung | MKM Partners | Neutral → Sell |
| 2021-02-12 | Herabstufung | Needham | Hold → Underperform |
| 2020-12-18 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-24 | Hochstufung | Stifel | Sell → Hold |
| 2020-05-22 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-15 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2020-02-27 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-02-25 | Eingeleitet | Needham | Hold |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-14 | Hochstufung | MKM Partners | Sell → Neutral |
| 2020-02-07 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
| 2020-01-10 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-23 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-09-24 | Eingeleitet | CIBC | Neutral |
Alle ansehen
Aurora Cannabis Inc. Aktie (ACB) Neueste Nachrichten
Aurora Cannabis Inc. Announces Appointment of Faris El Refaie as Executive Vice President, Global Commercial, Effective September 28, 2026 - marketscreener.com
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business - The Globe and Mail
Aurora Cannabis Rejects Curaleaf Offer as Inadequate - WSJ
Aurora Names Faris El Refaie EVP, Global Commercial - mg Magazine
What Is Shaping Interest in Aurora Cannabis Stock? (NASDAQ:ACB) - Kalkine Media
Aurora Cannabis Inc. stock falls Tuesday, underperforms market - MarketWatch
Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora - Cannabis Business Times
Curaleaf issues fact sheet defending bid to buy Aurora Cannabis - Bitget
Curaleaf Accuses Aurora of Misleading Shareholders in New "Fact Sheet" - StratCann
What Should Canadians Know About Aurora Cannabis Inc. (TSX:ACB)? - Kalkine Media
Why Aurora Cannabis Inc. (ACB) Is Trending on the TSX Right Now - kalkine.ca
Why Is Aurora Cannabis Inc (TSX:ACB) Turning Heads In Cannabis Stocks? - Kalkine Media
Aurora Cannabis Inc. (ACB): The Canadian Health Stock Investors May Want on Their Radar - kalkine.ca
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Aurora Cannabis (TSX:ACB): What Factors Are Shaping Shares? - Kalkine Media
Aurora Cannabis Inc. stock rises Friday, outperforms market - MarketWatch
Aurora Cannabis (NASDAQ:ACB): Can Sector Momentum Lift the Stock? - Kalkine Media
Aurora Cannabis Urges Shareholders to Reject Curaleaf’s Hostile Takeover - Ganjapreneur
Aurora Cannabis Stock Slides 3.59% as Selling Pressure Returns: Can Global Medical Cannabis Growth Stabilize TSX:ACB? - kalkine.ca
Why Aurora Cannabis Inc stock fell yesterday - Wealth Awesome
Aurora Cannabis Falls Under Pressure as Sentiment Weakens and Strategic Uncertainty Builds - kalkine.ca
StockTalk | Cannabis Report: Trading hostilities | 2026-09-04 | Investing News - stockhouse.com
Why Is Aurora Cannabis (NASDAQ:ACB) Board Telling Stockholders to Reject Curaleaf's Unsolicited Bid? - kalkinemedia.com
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora Cannabis (NASDAQ:ACB) In Focus Amid Changing Market Themes - kalkinemedia.com
Aurora Cannabis (NASDAQ:ACB) Draws Fresh Focus As Sector Shifts - kalkinemedia.com
Promising Cannabis Stocks To Follow TodaySeptember 3rd - MarketBeat
Aurora Cannabis Board Recommends Rejecting Curaleaf Bid - Yahoo Finance
Aurora Cannabis Urges Shareholders to Reject Curaleaf Hostile Takeover - Cannabis Equipment News
Aurora Rejects Curaleaf Bid, Opens Door to Other Offers - mg Magazine
Aurora Cannabis (NASDAQ:ACB) Faces Unsolicited Takeover Bid - Kalkine Media
Aurora Cannabis urges shareholders to reject hostile takeover offer by Curaleaf - CBC
Aurora Cannabis board rejects offer from Curaleaf (ACB:NASDAQ) - Seeking Alpha
Curaleaf (CURLF) answers Aurora Cannabis in new release - Stock Titan
A 45% bid premium for Aurora? Curaleaf Holdings (CURLF) makes its case - Stock Titan
Aurora Board Unanimously Rejects Curaleaf Proposal While US Company Counters - StratCann
Promising Cannabis Stocks To Watch NowSeptember 2nd - MarketBeat
Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid - Benzinga
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders - Yahoo! Finance Canada
Aurora Cannabis Urges Shareholders to Reject Curaleaf's Hostile Bid - Cannabis Business Times
Aurora's board tells shareholders to reject Curaleaf's bid and withdraw tendered shares - MMJDaily
Aurora Cannabis Board Rejects Curaleaf’s Hostile Bid, Urges Shareholders Not to Tender Shares - TipRanks
Aurora Cannabis urges shareholders to reject Curaleaf bid By Investing.com - Investing.com South Africa
ACB Looks 4.4% Overvalued on GF Value™ Amid Takeover Rejection - GuruFocus
Aurora Cannabis board rejects Curaleaf's unsolicited takeover bid - StreetInsider
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk - The Globe and Mail
Will Aurora Cannabis (NASDAQ:ACB) Stock Owners Back a Hostile Bid? - Kalkine Media
Aurora Cannabis Inc. Is Betting on Global Medical — Is ACB Finally a Higher-Quality Cannabis Story? - kalkine.ca
Top Cannabis Stocks Worth WatchingSeptember 1st - MarketBeat
Could Reclassification Headlines Redefine Tilray Brands (NASDAQ:TLRY) Across Global Cannabis Markets? - Kalkine Media
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid? - Yahoo Finance
Finanzdaten der Aurora Cannabis Inc.-Aktie (ACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):